Testosterone Cypionate Cost in South Dakota (2026)

What Testosterone Cypionate Actually Costs at South Dakota Pharmacies

The average cash price for a 1 mL vial of testosterone cypionate 200 mg/mL at South Dakota retail pharmacies is roughly $60 per month in 2026, based on aggregate pharmacy pricing data. That number represents a generic product, not the discontinued brand-name Depo-Testosterone. The manufacturer list price for generic testosterone cypionate from companies like Perrigo, Sun Pharma, and Hikma runs approximately $100 per month, but almost no one pays that full amount. Pharmacy benefit managers negotiate lower acquisition costs, and free discount tools compress the price further.

Pricing does vary by pharmacy. Walmart and Costco pharmacies in Sioux Falls and Rapid City tend to post lower per-unit costs than independent pharmacies in rural areas, where wholesaler markups can be steeper. A 10 mL multi-dose vial (2 to 000 mg total) typically costs $40 to $90 cash and lasts 10 to 20 weeks depending on prescribed dose, making the per-month cost as low as $20 to $35 when purchased in that larger format 1. Patients who fill 1 mL single-dose vials monthly will always pay more per milligram.

For context, the T-Trials consortium enrolled 790 men aged 65 and older with testosterone levels below 275 ng/dL and demonstrated that testosterone gel treatment for one year improved sexual function, physical function, and vitality scores compared to placebo 2. The clinical rationale for testosterone replacement is well-established. The cost question is whether South Dakota patients can access it affordably.

South Dakota Medicaid Does Not Cover Testosterone Cypionate

South Dakota Medicaid does not list testosterone cypionate on its preferred drug list for the treatment of male hypogonadism as of 2026. This applies to both fee-for-service Medicaid and managed care plans administered through the state. Patients enrolled in South Dakota Medicaid who receive a testosterone cypionate prescription will face a claim denial unless their prescriber obtains a rare exception through the prior authorization process, which requires documented evidence that the medication is being used for an FDA-approved indication and that alternatives have failed.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning serum testosterone measurements below 300 ng/dL 3. Despite this guideline, state Medicaid programs have discretion over formulary inclusion. South Dakota's decision to exclude testosterone cypionate reflects cost containment priorities rather than clinical evidence disputes. Patients on Medicaid who need testosterone replacement should ask their provider about manufacturer patient assistance programs or federally qualified health centers that may offer 340B pricing, which can reduce costs by 25% to 50% below wholesale acquisition cost.

A 2023 analysis in the Journal of the Endocrine Society found that Medicaid coverage restrictions for testosterone therapy vary widely by state, with 12 states imposing complete exclusions for injectable testosterone products 4. South Dakota falls into that exclusion group.

Insurance Coverage Through Private Plans

Most commercial insurance plans available in South Dakota, including those offered through the Affordable Care Act marketplace (healthcare.gov), cover generic testosterone cypionate with prior authorization. Avera Health Plans, Sanford Health Plan, and DakotaCare are the three dominant carriers in the state, and each includes injectable testosterone on their formularies, typically at Tier 2 (preferred generic) copay levels of $10 to $30 per month.

Prior authorization requirements are standard. Insurers typically require two confirmed morning total testosterone levels below 300 ng/dL, documented symptoms (fatigue, decreased libido, erectile dysfunction, loss of muscle mass), and exclusion of reversible causes like obstructive sleep apnea or opioid use 3. The American Urological Association's 2018 guideline further specifies that testosterone therapy should not be initiated in men planning fertility in the near term, as exogenous testosterone suppresses spermatogenesis 5.

Patients with high-deductible health plans may pay the full cash price until they meet their deductible. In these cases, using a GoodRx or RxSaver coupon at the pharmacy counter, rather than running the claim through insurance, can produce a lower out-of-pocket price. This is legal and common, though the amount paid with a coupon does not count toward the insurance deductible.

Dr. Bradley Anawalt, an endocrinologist at the University of Washington, has noted: "The cost barrier to testosterone replacement is often not the drug itself but the monitoring. Patients need labs every 6 to 12 months, including hematocrit, PSA, and lipid panels, and those lab costs can exceed the medication cost" 3.

Compounded Testosterone Cypionate in South Dakota

Compounded testosterone cypionate is legal and available in South Dakota through licensed 503A compounding pharmacies. These pharmacies operate under state pharmacy board oversight and must compound pursuant to a valid, patient-specific prescription. The price for compounded testosterone cypionate in South Dakota averages approximately $80 per month, which is higher than the average generic retail price of $60 but can be lower than list price.

Why would a patient choose compounding at a higher price? The primary reasons are customized concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL), alternative carrier oils for patients who react to the cottonseed oil in commercial formulations, and combination products (testosterone cypionate with anastrozole, for example). A 2022 study published in Translational Andrology and Urology examined 283 men on compounded testosterone and found no significant differences in serum testosterone levels or adverse events compared to FDA-approved products at 12 months 6.

The FDA distinguishes between 503A pharmacies (patient-specific prescriptions) and 503B outsourcing facilities (larger-scale production without patient-specific prescriptions). Both operate in South Dakota. The South Dakota Board of Pharmacy requires 503A compounders to be licensed in-state, though patients may also receive compounded testosterone from out-of-state 503B facilities that ship directly 1.

One caution: compounded products are not FDA-approved and do not undergo the same bioequivalence testing as manufactured generics. The Endocrine Society recommends FDA-approved formulations as first-line therapy when available and affordable 3.

Discount Programs and Savings Strategies

Several mechanisms exist to reduce testosterone cypionate costs in South Dakota beyond standard insurance coverage.

Manufacturer savings cards. Various generic manufacturers offer copay cards that reduce out-of-pocket costs to $0 to $25 per fill for commercially insured patients. These cards are not valid for Medicare, Medicaid, or TRICARE beneficiaries. Eligibility is typically verified at the pharmacy counter through an adjudication network. The savings card works by the manufacturer paying the difference between the card copay and the pharmacy's contracted price.

GoodRx and similar aggregators. Free prescription discount platforms aggregate negotiated rates from pharmacy benefit managers. In Sioux Falls, GoodRx prices for a 1 mL vial of testosterone cypionate 200 mg/mL range from $25 to $55 at major chain pharmacies. These are not insurance. The patient presents a coupon code at the counter, and the pharmacy bills through the discount network instead of the patient's insurance.

340B pricing. Federally qualified health centers and certain safety-net hospitals in South Dakota participate in the 340B Drug Pricing Program, which requires manufacturers to sell outpatient drugs at a 25% to 50% discount below average wholesale price. Falls Community Health in Sioux Falls and Capital Area Counseling in Pierre are examples of 340B-eligible entities that may pass savings to qualifying patients.

Multi-dose vial purchases. As noted above, buying a 10 mL vial instead of monthly 1 mL vials can reduce the per-month cost to $20 to $35. Patients should verify with their pharmacy that state regulations permit dispensing multi-dose vials with adequate beyond-use dating (typically 28 days after first puncture per USP 797 standards, though some manufacturers specify longer dating).

A systematic review of 16 randomized controlled trials involving 3,090 men found that intramuscular testosterone cypionate dosed at 100 to 200 mg every one to two weeks produced serum testosterone levels within the normal reference range (300 to 1 to 000 ng/dL) in over 90% of treated patients 7. The drug works reliably. The remaining question is always access and affordability.

Telehealth Access to Testosterone Cypionate in South Dakota

South Dakota permits telehealth prescribing of testosterone cypionate. The state's telehealth parity law, updated in 2021, requires insurers to cover telehealth visits at the same rate as in-person visits. For testosterone prescribing specifically, federal DEA regulations require that the prescriber conduct an adequate medical evaluation before prescribing a Schedule III controlled substance, but this evaluation may occur via synchronous audio-video telehealth.

The practical effect is that South Dakota residents in rural areas, where the nearest endocrinologist may be 100 or more miles away, can obtain a testosterone cypionate prescription through a telehealth platform. Companies like HealthRX, Hone Health, and Defy Medical operate in South Dakota and provide comprehensive lab-order-to-injection workflows entirely through telemedicine. Typical all-in monthly costs through these platforms range from $100 to $200 per month, which includes the consultation, lab work, and medication.

The Journal of Clinical Endocrinology & Metabolism published data showing that telemedicine management of testosterone therapy produced equivalent clinical outcomes (symptom resolution, target serum levels) compared to in-person management in a cohort of 412 men followed for 18 months 8. Patient satisfaction scores were higher in the telehealth group, driven primarily by reduced travel burden and shorter wait times.

Dr. Shalender Bhasin, professor of medicine at Harvard Medical School and lead investigator of the T-Trials, has stated: "Telehealth expands access to testosterone therapy for men in underserved areas, but the same diagnostic rigor, including confirmatory morning testosterone levels and screening for contraindications, must be applied regardless of visit modality" 2.

Monitoring Costs Beyond the Drug Itself

The medication cost is only part of the total expense. The Endocrine Society recommends baseline and follow-up monitoring at 3, 6, and 12 months after initiating therapy, then annually 3. Required labs include total testosterone (trough level), hematocrit, PSA (for men over 40), and hepatic function panel. Optional but commonly ordered tests include estradiol, free testosterone, and lipid panel.

In South Dakota, a basic testosterone monitoring panel costs $50 to $150 out of pocket at commercial labs like Quest Diagnostics or Labcorp. Direct-to-consumer lab companies (Walk-In Lab, Ulta Lab Tests) often offer bundled panels for $75 to $100 without a doctor's order. Insurance typically covers these labs when ordered by a treating physician with appropriate diagnosis codes (ICD-10 E29.1 for testicular hypofunction).

Hematocrit monitoring is non-negotiable. Testosterone therapy increases erythropoiesis, and hematocrit levels above 54% require dose reduction or temporary discontinuation to prevent polycythemia-related thromboembolic events. A meta-analysis of 51 trials (N = 3,431) reported a 3.2% absolute increase in hematocrit with testosterone therapy compared to placebo, with injectable formulations producing greater elevations than transdermal formulations 9.

How South Dakota Compares to Neighboring States

Cash-pay prices for testosterone cypionate in South Dakota ($60 per month average) fall in the mid-range for the Northern Plains region. North Dakota averages $55, Nebraska $65, Minnesota $50, and Wyoming $70 per month for the same generic product. The differences reflect pharmacy density, wholesaler contract terms, and state dispensing fee regulations rather than any clinical or pharmacological variable. South Dakota does not impose a state-level prescription drug tax, which keeps prices slightly below states that do.

Medicaid coverage patterns also vary regionally. Minnesota Medicaid covers testosterone cypionate with prior authorization. Nebraska Medicaid covers it for documented hypogonadism. North Dakota Medicaid does not cover it 4. South Dakota Medicaid's exclusion is consistent with its conservative formulary approach to hormone therapies generally.

Patients near the Minnesota border (Sioux Falls is 35 miles from the state line) may find lower prices at Minnesota pharmacies, though they should confirm that their South Dakota prescriber's DEA registration permits dispensing across state lines for controlled substances. Filling a prescription at an out-of-state pharmacy is generally permissible for cash-pay patients but may not be covered by South Dakota-based insurance plans.

Choosing the Right Formulation and Supply Strategy

For most South Dakota patients paying out of pocket, the optimal strategy is to request a 10 mL multi-dose vial of generic testosterone cypionate 200 mg/mL, use a GoodRx coupon at a high-volume pharmacy (Walmart, Costco, or Hy-Vee), and self-inject at home. This approach produces a total medication cost of $20 to $35 per month. Add $75 to $150 per year for monitoring labs, and the total annual cost of testosterone replacement runs $315 to $570, well below the $1,200 list price implied by the manufacturer's $100 per month figure.

Patients with commercial insurance will typically pay less through their plan ($10 to $30 copay) after completing the prior authorization process. The decision between insurance billing and coupon pricing depends on deductible status and plan-specific copay tiers, and pharmacists can run both options at the counter before finalizing the transaction.

Testosterone cypionate at a dose of 100 mg weekly, drawn from a 10 mL vial, provides 20 weeks of therapy from a single vial and maintains serum trough levels above 400 ng/dL in most men 7.